Merck & Co. is in late-stage talks to amass Prometheus Biosciences Inc., in line with individuals acquainted with the matter, a transfer that might give the massive drugmaker promising immune illness remedies.
Merck & Co. is in late-stage talks to amass Prometheus Biosciences Inc., in line with individuals acquainted with the matter, a transfer that might give the massive drugmaker promising immune illness remedies.
Sign in to your account